跳至主要内容
临床试验/TCTR20150608001
TCTR20150608001已完成2 期

Parenteral parecoxib provides similar analgesic efficacy to single-shot sciatic nerve block after total knee arthroplasty when combined with continuous femoral nerve block

Faculty of Medicine Ramathibodi Hospital, Mahidol University0 个研究点目标入组 78 人开始时间: 2015年6月8日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
78

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
0 Years 至 100 Years(—)
性别
All

入选标准

  • - Adults undergoing unilateral TKA
  • - Written informed consent obtained

排除标准

  • - Infection at the planned site of skin puncture, coagulopathy, known allergy to local anesthetics, and inability to operate a patient-controlled analgesia device (PCA). Patients with relative contraindications to intravenous parecoxib, such as coronary artery disease, cerebrovascular disease, asthma and severe renal function impairment.

研究者

相似试验